nach oben

Erschienen in:

05.09.2021 | Dentistry • Review

Effects of oral appliances on serum cytokines in adults with obstructive sleep apnea: a systematic review

verfasst von: Paulo Mecenas, Giza Hellen Nonato Miranda, Nathalia Carolina Fernandes Fagundes, David Normando, Karina Correa Flexa Ribeiro

Erschienen in: Sleep and Breathing | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This review aimed to evaluate the effects of oral appliance (OA) therapy on serum inflammatory cytokines in adults diagnosed with obstructive sleep apnea (OSA).

Methods

Seven electronic databases and partial gray literature were searched without restrictions through March 2021. Articles evaluating the levels of serum inflammatory cytokines in patients with OSA after OA treatment were included. The risk of bias (RoB) was assessed using the before-and-after tool or RoB 2.0. The level of certainty was assessed using the GRADE tool.

Results

Five studies met the eligibility criteria. One was a randomized clinical trial (RCT), while four were non-randomized clinical trials (NRCTs). Among the studies, C-reactive protein (CRP), IL-6, IL-10, IL-1β, and tumor necrosis factor α (TNF-α) were investigated. The RCT reported no significant differences in marker levels after 2 months of OA therapy, while the NRCTs showed improvement on CRP, TNF-α, and IL-1β levels after longer follow-up periods. The RoB was evaluated as showing some concern in the RCT. Three NRCTs presented good RoB, and one showed a fair RoB. The level of certainty was graded as moderate quality for inflammatory marker levels assessed in the RCT The levels of certainty evaluated in NRCTs were classified as very low.

Conclusions

Although limited, existing scientific evidence showed that OA therapy may improve serum cytokine levels in adults with OSA. However, short treatment periods are not effective in reducing markers of systemic inflammation which may require extended time and a decrease of in apneic events to improve.

Nur mit Berechtigung zugänglich

Park JG, Ramar K, Olson EJ (2011) Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clin Proc 86(6):549–555. https://doi.org/10.4065/mcp.2010.0810CrossRefPubMedPubMedCentral

Punjabi NM (2008) The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5(2):136–143. https://doi.org/10.1513/pats.200709-155MGCrossRefPubMedPubMedCentral

Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177(9):1006–1014. https://doi.org/10.1093/aje/kws342CrossRefPubMedPubMedCentral

Rapoport DM (2016) POINT: is the apnea-hypopnea index the best way to quantify the severity of sleep-disordered breathing? Yes Chest 149(1):14–16. https://doi.org/10.1378/chest.15-1319CrossRefPubMed

Punjabi NM (2016) COUNTERPOINT: is the apnea-hypopnea index the best way to quantify the severity of sleep-disordered breathing? No Chest 149(1):16–19. https://doi.org/10.1378/chest.14-2261CrossRefPubMed

Fallahi A, Jamil DI, Karimi EB, Baghi V, Gheshlagh RG (2019) Prevalence of obstructive sleep apnea in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Syndr 13(4):2463–2468. https://doi.org/10.1016/j.dsx.2019.06.030CrossRefPubMed

Hou H, Zhao Y, Yu W, Dong H, Xue X, Ding J et al (2018) Association of obstructive sleep apnea with hypertension: a systematic review and meta-analysis. J Glob Health 8(1):010405. https://doi.org/10.7189/jogh.08.010405CrossRefPubMedPubMedCentral

McKee Z, Auckley DH (2019) A sleeping beast: obstructive sleep apnea and stroke. Cleve Clin J Med 86(6):407–415. https://doi.org/10.3949/ccjm.86a.18033CrossRefPubMed

Coman AC, Borzan C, Vesa CS, Todea DA (2016) Obstructive sleep apnea syndrome and the quality of life. Clujul Med 89(3):390–395. https://doi.org/10.15386/cjmed-593

10.

Andersen ML, Santos-Silva R, Bittencourt LR, Tufik S (2010) Prevalence of erectile dysfunction complaints associated with sleep disturbances in Sao Paulo, Brazil: a population-based survey. Sleep Med 11(10):1019–1024. https://doi.org/10.1016/j.sleep.2009.08.016CrossRefPubMed

11.

Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H et al (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9(10):1003–1012. https://doi.org/10.5664/jcsm.3070CrossRefPubMedPubMedCentral

12.

Lavie L (2003) Obstructive sleep apnoea syndrome–an oxidative stress disorder. Sleep Med Rev 7(1):35–51. https://doi.org/10.1053/smrv.2002.0261CrossRefPubMed

13.

Labarca G, Gower J, Lamperti L, Dreyse J, Jorquera J (2019) Chronic intermittent hypoxia in obstructive sleep apnea: a narrative review from pathophysiological pathways to a precision clinical approach. Sleep Breath 24(2):751–760. https://doi.org/10.1007/s11325-019-01967-4CrossRefPubMed

14.

Lavie L, Lavie P (2009) Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 33(6):1467–1484. https://doi.org/10.1183/09031936.00086608CrossRefPubMed

15.

Oguntibeju OO (2019) Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol 11(3):45–63PubMedPubMedCentral

16.

Schwartz M, Acosta L, Hung YL, Padilla M, Enciso R (2018) Effects of CPAP and mandibular advancement device treatment in obstructive sleep apnea patients: a systematic review and meta-analysis. Sleep Breath 22(3):555–568. https://doi.org/10.1007/s11325-017-1590-6CrossRefPubMed

17.

Rotenberg BW, Murariu D, Pang KP (2016) Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol Head Neck Surg 45:43. https://doi.org/10.1186/s40463-016-0156-0CrossRefPubMedPubMedCentral

18.

Sharples LD, Clutterbuck-James AL, Glover MJ, Bennett MS, Chadwick R, Pittman MA et al (2016) Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea. Sleep Med Rev 27:108–124. https://doi.org/10.1016/j.smrv.2015.05.003CrossRefPubMed

19.

Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM et al (2015) Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med 11(7):773–827. https://doi.org/10.5664/jcsm.4858CrossRefPubMedPubMedCentral

20.

Chan AS, Sutherland K, Schwab RJ, Zeng B, Petocz P, Lee RW et al (2010) The effect of mandibular advancement on upper airway structure in obstructive sleep apnoea. Thorax 65(8):726–732. https://doi.org/10.1136/thx.2009.131094CrossRefPubMed

21.

Serra-Torres S, Bellot-Arcis C, Montiel-Company JM, Marco-Algarra J, Almerich-Silla JM (2016) Effectiveness of mandibular advancement appliances in treating obstructive sleep apnea syndrome: a systematic review. Laryngoscope 126(2):507–514. https://doi.org/10.1002/lary.25505CrossRefPubMed

22.

de Vries GE, Wijkstra PJ, Houwerzijl EJ, Kerstjens HAM, Hoekema A (2018) Cardiovascular effects of oral appliance therapy in obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med Rev 40:55–68. https://doi.org/10.1016/j.smrv.2017.10.004CrossRefPubMed

23.

Fernandez-Julian E, Perez-Carbonell T, Marco R, Pellicer V, Rodriguez-Borja E, Marco J (2018) Impact of an oral appliance on obstructive sleep apnea severity, quality of life, and biomarkers. Laryngoscope 128:1720–1726. https://doi.org/10.1002/lary.26913CrossRefPubMed

24.

Nizankowska-Jedrzejczyk A, Almeida FR, Lowe AA, Kania A, Nastalek P, Mejza F et al (2014) Modulation of inflammatory and hemostatic markers in obstructive sleep apnea patients treated with mandibular advancement splints: a parallel, controlled trial. J Clin Sleep Med 10(3):255–262. https://doi.org/10.5664/jcsm.3522CrossRefPubMedPubMedCentral

25.

Oh J-T, Chung J-W, Pain (2016) Inflammatory cytokine level in patients with obstructive sleep apnea and treatment outcome of oral appliance therapy. J Oral Med Pain 41(3):126–132. https://doi.org/10.14476/jomp.2016.41.3.126

26.

Recoquillon S, Pepin JL, Vielle B, Andriantsitohaina R, Bironneau V, Chouet-Girard F et al (2019) Effect of mandibular advancement therapy on inflammatory and metabolic biomarkers in patients with severe obstructive sleep apnoea: a randomised controlled trial. Thorax 74(5):496–499. https://doi.org/10.1136/thoraxjnl-2018-212609CrossRefPubMed

27.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

28.

National Institutes of Health NH, Lung and Blood Institute. Quality assessment tool for before–after (pre–post) studies with no control group. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 16 May 2021

29.

Stern JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 28(366):l4898. https://doi.org/10.1136/bmj.l4898CrossRef

30.

Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64(4):401–406. https://doi.org/10.1016/j.jclinepi.2010.07.015CrossRefPubMed

31.

Galic T, Bozic J, Ivkovic N, Gunjaca G, Ticinovic TK, Dogas Z (2016) Effects of mandibular advancement device treatment on arterial stiffness and glucose metabolism in patients with mild to moderate obstructive sleep apnea: a prospective 1 year study. Sleep Breath 20(1):69–77. https://doi.org/10.1007/s11325-015-1186-yCrossRefPubMed

32.

Kent BD, Ryan S, McNicholas WT (2011) Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 178(3):475–481. https://doi.org/10.1016/j.resp.2011.03.015CrossRefPubMed

33.

Hatipoglu U, Rubinstein I (2003) Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70(6):665–671. https://doi.org/10.1159/000075218CrossRefPubMed

34.

Wang J, Yu W, Gao M, Zhang F, Gu C, Yu Y et al (2015) Impact of obstructive sleep apnea syndrome on endothelial function, arterial stiffening, and serum inflammatory markers: an updated meta-analysis and metaregression of 18 studies. J Am Heart Assoc 4(11):e002454. https://doi.org/10.1161/JAHA.115.002454CrossRefPubMedPubMedCentral

35.

Constantinidis J, Ereliadis S, Angouridakis N, Konstantinidis I, Vital V, Angouridaki C (2008) Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol 265(10):1275–1279. https://doi.org/10.1007/s00405-008-0627-7CrossRefPubMed

36.

Kezirian EJ, Malhotra A, Goldberg AN, White DP (2010) Changes in obstructive sleep apnea severity, biomarkers, and quality of life after multilevel surgery. Laryngoscope 120(7):1481–1488. https://doi.org/10.1002/lary.20946CrossRefPubMedPubMedCentral

37.

Thunstrom E, Glantz H, Yucel-Lindberg T, Lindberg K, Saygin M, Peker Y (2017) CPAP does not reduce inflammatory biomarkers in patients with coronary artery disease and nonsleepy obstructive sleep apnea: a randomized controlled trial. Sleep 40(11). https://doi.org/10.1093/sleep/zsx157

38.

Chirinos JA, Gurubhagavatula I, Teff K, Rader DJ, Wadden TA, Townsend R et al (2014) CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 370(24):2265–2275. https://doi.org/10.1056/NEJMoa1306187CrossRefPubMedPubMedCentral

39.

Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H et al (2013) Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis. J Inflamm (Lond) 10:13. https://doi.org/10.1186/1476-9255-10-13CrossRef

40.

Xie X, Pan L, Ren D, Du C, Guo Y (2013) Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med 14(11):1139–1150. https://doi.org/10.1016/j.sleep.2013.07.006CrossRefPubMed

41.

Canto Gde L, Pacheco-Pereira C, Aydinoz S, Major PW, Flores-Mir C, Gozal D (2015) Biomarkers associated with obstructive sleep apnea: a scoping review. Sleep Med Rev 23:28–45. https://doi.org/10.1016/j.smrv.2014.11.004CrossRefPubMed

42.

Wong TK (2011) The search on an ideal disease marker for childhood obstructive sleep apnea syndrome. Sleep 34(2):133–134. https://doi.org/10.1093/sleep/34.2.133CrossRefPubMedPubMedCentral

43.

Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC (1990) Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12(5):1179–1186. https://doi.org/10.1002/hep.1840120517CrossRefPubMed

44.

Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM (2001) Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 47(3):426–430CrossRef

45.

Bhushan B, Guleria R, Misra A, Pandey RM, Luthra K, Vikram NK (2009) Obstructive sleep apnoea correlates with C-reactive protein in obese Asian Indians. Nutr Metab Cardiovasc Dis 19(3):184–189. https://doi.org/10.1016/j.numecd.2008.06.008CrossRefPubMed

46.

Chien MY, Lee P, Tsai YF, Yang PC, Wu YT (2012) C-reactive protein and heart rate recovery in middle-aged men with severe obstructive sleep apnea. Sleep Breath 16(3):629–637. https://doi.org/10.1007/s11325-011-0549-2CrossRefPubMed

47.

Sharma SK, Mishra HK, Sharma H, Goel A, Sreenivas V, Gulati V et al (2008) Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 9(2):149–156. https://doi.org/10.1016/j.sleep.2007.02.004CrossRefPubMed

48.

Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62(6):509–514. https://doi.org/10.1136/thx.2006.066720CrossRefPubMedPubMedCentral

49.

Khalyfa A, Kheirandish-Gozal L, Gozal D (2018) Exosome and macrophage crosstalk in sleep-disordered breathing-induced metabolic dysfunction. Int J Mol Sci 19(11):3383. https://doi.org/10.3390/ijms19113383CrossRefPubMedCentral

50.

Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E (2007) Correlates of serum C-reactive protein (CRP)–no association with sleep duration or sleep disordered breathing. Sleep 30(8):991–996. https://doi.org/10.1093/sleep/30.8.991CrossRefPubMedPubMedCentral

51.

Lopez-Padros C, Salord N, Alves C, Vilarrasa N, Gasa M, Planas R et al (2020) Effectiveness of an intensive weight-loss program for severe obstructive sleep apnea syndrome (OSA) in patients undergoing CPAP treatment: a randomized controlled trial. J Clin Sleep Med 16(4):503–514. https://doi.org/10.5664/jcsm.8252CrossRefPubMedPubMedCentral

52.

Perrini S, Cignarelli A, Quaranta VN, Falcone VA, Kounaki S, Porro S et al (2017) Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea. JCI insight 2(17):e94379. https://doi.org/10.1172/jci.insight.94379CrossRefPubMedCentral

53.

Yadav R, France M, Aghamohammadzadeh R, Liu Y, Hama S, Kwok S et al (2014) Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea. J Clin Endocrinol Metab 99(9):3390–3398. https://doi.org/10.1210/jc.2013-3939CrossRefPubMed

54.

Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106(5):506–512. https://doi.org/10.1016/s0002-9343(99)00066-2CrossRefPubMed

55.

Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134. https://doi.org/10.1161/01.cir.0000052627.99976.18CrossRefPubMed

56.

Li Y, Chongsuvivatwong V, Geater A, Liu A (2008) Are biomarker levels a good follow-up tool for evaluating obstructive sleep apnea syndrome treatments? Respiration 76(3):317–323. https://doi.org/10.1159/000119542CrossRefPubMed

57.

Sahlman J, Miettinen K, Peuhkurinen K, Seppa J, Peltonen M, Herder C et al (2010) The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res 19(2):341–348. https://doi.org/10.1111/j.1365-2869.2009.00787.xCrossRefPubMed

58.

Shiina K, Tomiyama H, Takata Y, Yoshida M, Kato K, Nishihata Y et al (2012) Overlap syndrome: additive effects of COPD on the cardiovascular damages in patients with OSA. Respir Med 106(9):1335–1341. https://doi.org/10.1016/j.rmed.2012.05.006CrossRefPubMed

59.

Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82(5):1313–1316. https://doi.org/10.1210/jcem.82.5.3950CrossRefPubMed

60.

Kheirandish-Gozal L, Gozal D (2019) Obstructive sleep apnea and inflammation: proof of concept based on two illustrative cytokines. Int J Mol Sci 20(3):459. https://doi.org/10.3390/ijms20030459CrossRefPubMedCentral

61.

Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28(2):87–91. https://doi.org/10.1016/j.cyto.2004.07.003CrossRefPubMed

62.

Groux H, Cottrez F (2003) The complex role of interleukin-10 in autoimmunity. J Autoimmun 20(4):281–285. https://doi.org/10.1016/s0896-8411(03)00044-1CrossRefPubMed

63.

Ozdas S, Ozdas T, Acar M, Erbek SS, Koseoglu S, Gokturk G et al (2016) Association of interleukin-10 gene promoter polymorphisms with obstructive sleep apnea. Sleep Breath 20(2):855–866. https://doi.org/10.1007/s11325-015-1216-9CrossRefPubMed

64.

Herlenius E (2011) An inflammatory pathway to apnea and autonomic dysregulation. Respir Physiol Neurobiol 178(3):449–457. https://doi.org/10.1016/j.resp.2011.06.026CrossRefPubMed

Titel: Effects of oral appliances on serum cytokines in adults with obstructive sleep apnea: a systematic review
verfasst von: Paulo Mecenas
Giza Hellen Nonato Miranda
Nathalia Carolina Fernandes Fagundes
David Normando
Karina Correa Flexa Ribeiro
Publikationsdatum: 05.09.2021
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 3/2022
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-021-02485-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Effects of oral appliances on serum cytokines in adults with obstructive sleep apnea: a systematic review